Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?

Related Experiment Video

Updated: Aug 25, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

K Morozumi1, A Takeda, K Uchida

  • 1Kidney Center, Nagoya Daini Red Cross Hospital, Nagoya, Japan. morozumi@nagoya2.jrc.or.jp

Transplantation Proceedings
|March 26, 2004
PubMed

Insights

Chronic CSA nephrotoxicity, a cause of graft failure, involves CSA-associated arteriolopathy (CAA). Chronic rejection, not CAA severity, predicts graft loss, but managing CAA with lower CSA doses may slow dysfunction.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Pathology

Background:

  • Chronic calcineurin inhibitor (CSA) nephrotoxicity is a major cause of late renal allograft failure.
  • CSA-associated arteriolopathy (CAA) is a key lesion, but its significance has evolved with reduced CSA doses and therapeutic drug monitoring.
  • Understanding CAA's impact is crucial for long-term graft survival.

Purpose of the Study:

  • To investigate the clinicopathological characteristics of CAA in renal transplant recipients.
  • To determine the prognostic significance of CAA severity and coexisting lesions, particularly chronic rejection and focal segmental glomerulosclerosis (FGS), for graft loss.
  • To evaluate the impact of modified CSA dosing strategies on graft function in patients with CAA.

Main Methods:

  • Retrospective analysis of 74 renal transplant recipients with CAA on CSA therapy.
  • Classification of patients into functioning graft (n=30) and graft loss (n=44) groups.
  • Histopathological assessment of CAA severity, chronic rejection, and FGS lesions; correlation with clinical outcomes and CSA blood levels.

Main Results:

  • No significant difference in CAA severity was observed between functioning and loss groups.
  • Concomitant chronic rejection lesions, not CAA severity, were the primary risk factor for graft loss.
  • Focal segmental glomerulosclerosis (FGS) lesions accompanying CAA (CSA-associated glomerulopathy, CAG) were associated with graft loss; lower CSA doses slowed dysfunction in some CAG patients, but proteinuria >2g/day predicted graft failure.

Conclusions:

  • Chronic rejection is a more significant predictor of graft loss than CAA severity in renal transplant recipients on CSA.
  • CSA-associated glomerulopathy (CAG), characterized by FGS lesions with CAA, requires careful management, including potentially reduced CSA doses.
  • Isolated severe CAA has a good prognosis with controlled CSA therapy, highlighting the importance of managing coexisting lesions and proteinuria for long-term graft survival.

More Related Videos

Mouse Kidney Transplantation: Models of Allograft Rejection16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...